Patent Yard Sign in
Expired Australian patentAustralia

A method for treating allergic and inflammatory diseases and for inhibiting the production of tumor necrosis factor

AU 1999036759 · Applicant: Smithkline Beecham Corporation

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 24, 1999 and granted January 11, 2001. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by June 24, 2020.
  • A pharmaceutical extension adds at most five years, so even that would have ended by June 24, 2025.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 24, 1999
GrantedJanuary 11, 2001
Term ended byJune 24, 2020
Application numberAU 1999036759
Classification (IPC)C07C69/712 +2 more

Timeline

Timeline From IP Australia dates

2000200320062009201220152018Application filedJune 24, 1999Patent grantedJan 11, 2001Term ended byJune 24, 2020

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.